ER for scientists with little finance experience

Hello everyone,

I know it is a bit intrusive to start out in a forum by posing a question, but I thought there is no place better to get some of the answers I seek.

I am hoping to break into equity research and I am in need of a bit of guidance and perhaps a reality check. I have an undergraduate degree in neuroscience from a very well known and respected school and a master's degree in biomedical neurobiology from another well known medical school. I have extensive clinical and core research experience and have applied my expertise as a biotech consultant, helping new medical device companies with product development, etc. I also teach first year medical students preclinical courses at Harvard and BU. Over the course of the last few years, especially as a contracted consultant, I have developed a real passion for markets. In many ways equity research mirrors the methods of scientific research, or at the very least it encompasses a dynamic I am familiar with. I have opted not to continue forward with a PhD (hence my master's degree), since a PhD has no real practical value outside of academia in most respects...I would rather gain more work experience and go to business school. I have been networking aggressively and have passed my resume along and have had some information sessions. However, my real finance exposure in a formal sense is limited...I understand the basics of DCF, can "slowly" work my way through financial statements but I have no real modeling experience or knowledge.

In your opinion, what is my best option? Is my lack of real finance experience despite my industry and academic credentials at brand name institutions a real negative?

Thanks so much for your opinions!

 
Best Response

You're very niche. You have great industry experience that is directly applicable to the medtech and bio teams but there are probably only about 100 or so sellside research associate spots in the industry as a whole covering those industries. Since you would be an industry hire have you thought about contacting any headhunters. This is probably the worst timing to get into ER as we are in a structural contraction phase. An MBA can work as you would have access to OCR and your nonfinance background provides the perfect story on why you want to get an MBA.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
numi's picture
numi
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”